000			03905nam a22004095i 4500
999			_c9628 _d9628
001			9628
003			DE-He213
005			20210518040406.0
006			a||||fo|||| 00| 0
007			cr nn 008mamaa
008			171112s2018 gw | s |||| 0|eng d
020			_a9783319575803
024	7		_a10.1007/978-3-319-57580-3 _2doi
040			_aES-MaUEC _bspa _dES-VaUE
050		4	_aRS431 _b.S24 2018 EB
100	1		_aSaha, Gopal B _eautor _4aut _4http://id.loc.gov/vocabulary/relators/aut _0http://id.loc.gov/authorities/names/n79068942 _0http://viaf.org/viaf/5113912
245	1	0	_aFundamentals of Nuclear Pharmacy _cby Gopal B. Saha.
250			_a7th edition
264		1	_aCham _bSpringer International Publishing : _bImprint: Springer _c2018.
300			_a1 recurso en línea (XVII, 428 páginas 110 ilustraciones, 31 ilustraciones a color)
336			_2rdacontent _aTexto (visual) _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_atext file _bPDF
490	0		_aMedicine (Springer-11650)
505	0		_aThe Atom -- Radioactive Decay -- Instruments for Radiation Detection and Measurement -- Production of Radionuclides -- Radionuclide Generators -- Radiopharmaceuticals and Methods of Radiolabeling -- Characteristics of Specific Radiopharmaceuticals -- Quality Control of Radiopharmaceuticals -- Nuclear Pharmacy -- Internal Radiation Dosimetry -- Radiation Regulations, Protection, and Uses -- In Vitro and In Vivo Nonimaging Tests -- Diagnostic Uses of Radiopharmaceuticals in Nuclear Medicine -- Molecular Imaging -- Therapeutic Uses of Radiopharmaceuticals in Nuclear Medicine -- Adverse Reactions to and Altered Biodistribution of Radiopharmaceuticals.
520	3		_aCurrently an estimated 17 million nuclear medicine procedures are performed each year in the US and constantly evolving, as new radiopharmaceuticals and imaging techniques are introduced for better diagnosis and treatment of human diseases. In keeping up with new developments, the Seventh Edition of Fundamentals of Nuclear Pharmacy chronicles the advancements in radiopharmaceuticals and their use in clinical applications. It discusses basic concepts such as the atom, radioactive decay, instrumentation and production of radionuclides, and explores the design, labeling, characteristics and quality control of radiopharmaceuticals. Radiation regulations and diagnostic and therapeutic applications of radiopharmaceuticals are detailed. Thoroughly updated, the Seventh Edition includes new topics such as alternative productions of 99Mo; production of 64Cu, 86Y, 89Zr, 177Lu, 223Ra; synthesis and clinical uses of new radiopharmaceuticals such as DaTscan, Xofigo, Amyvid, Neuraceq, Vizamyl, Axumin and 68Ga-DOTATATE; dosimetry of new radiopharmaceuticals; theranostic agents and translational medicine. It features numerous examples, diagrams, and images to further clarify the information and offers end- of-chapter questions to help readers assess their comprehension of the material. Recognized as a classic text on nuclear chemistry and pharmacy and acclaimed for its concise and easy-to-understand presentation, Fundamentals of Nuclear Pharmacy is an authoritative resource for nuclear medicine physicians, residents, students, and technologists. .
650		7	_aProductos radiofarmacéuticos _9141446 _2embne
650		7	_9138396 _aMedicina nuclear _2embne
710	2		_aSpringerLink (Online service) _0http://id.loc.gov/authorities/names/no2005046756 _0http://viaf.org/viaf/148105729 _9106996
776	0	8	_iEdición impresa: _z9783319575797
776	0	8	_iEdición impresa: _z9783319575810
776	0	8	_iEdición impresa: _z9783319862002
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-319-57580-3 _zAcceso a este recurso digital (usuarios Universidad Europea de Valencia)
942			_2lcc _cLE
998			_db